CORM-A1 Alleviates Pro-Atherogenic Manifestations via miR-34a-5p Downregulation and an Improved Mitochondrial

Hitarthi S Vyas1, Ravirajsinh N Jadeja2, Aliasgar Vohra1

  • 1Chronobiology and Metabolic Endocrinology Lab, Department of Zoology, Faculty of Science, The Maharaja Sayajirao University of Baroda, Vadodara 390002, India.

Insights

Carbon monoxide (CO) from CORM-A1 donor reduces oxidative stress and mitochondrial dysfunction in atherosclerosis. This CO therapy inhibits miR-34a-5p, restoring mitochondrial function and energetics, offering a novel therapeutic approach.

Area of Science:

  • Cardiovascular Biology
  • Mitochondrial Medicine
  • Oxidative Stress Research

Background:

  • Atherogenesis involves cellular metabolic dysfunction, increased reactive oxygen species (ROS), and oxidative stress.
  • The role of carbon monoxide (CO) in mitigating these atherosclerotic processes, particularly concerning ROS and mitochondrial health, remains largely unexplored.

Purpose of the Study:

  • To investigate the anti-atherogenic effects of CORM-A1, a CO-releasing molecule, in vitro and in vivo.
  • To elucidate the underlying mechanisms, focusing on microRNA-34a-5p (miR-34a-5p) regulation and mitochondrial function.

Main Methods:

  • Utilized in vitro models (ox-LDL-treated HUVECs and MDMs) and an in vivo model (atherogenic diet-fed SD rats).
  • Assessed the impact of CORM-A1 on miR-34a-5p expression, transcription factors (P53, NF-κB, ZEB1, SNAI1, STAT3), DNA methylation, mitochondrial biogenesis, ROS levels, cellular respiration (OCR, ECAR), and ATP production.

Main Results:

  • CORM-A1 administration normalized elevated miR-34a-5p levels in atherogenic models.
  • CO treatment via CORM-A1 restored SIRT-1 levels, promoted mitochondrial biogenesis, enhanced antioxidant capacity, and reduced ROS.
  • CORM-A1 improved cellular energetics, restoring respiration and increasing ATP production in both in vitro and in vivo systems.

Conclusions:

  • CORM-A1 demonstrates significant anti-atherogenic efficacy by inhibiting miR-34a-5p expression.
  • This mechanism rescues SIRT1-mediated mitochondrial biogenesis and function, ameliorating pro-atherogenic conditions.
  • CO therapy presents a promising strategy for treating atherosclerosis by targeting mitochondrial dysfunction and oxidative stress.

Related Concept Videos

Lipid Catabolism01:25

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
109
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
14.0K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Mitochondrial Precursor Proteins01:39

Mitochondrial Precursor Proteins

Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70  chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
2.6K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
608